BMY vs ZUMZ · P/E 17, rev $24.46B vs rev $929.1M
Bristol-Myers Squibb Company (BMY) versus Zumiez Inc (ZUMZ) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
Zumiez Inc (ZUMZ) is a apparel retail company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported ZUMZ revenue for 2026-01-31 was $929.1M. Net income was $13.4M. ZUMZ currently screens at market cap $349.1M.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. ZUMZ currently screens at market cap $349.1M.
Not investment advice. Open the BMY and ZUMZ stock pages for the full models.
Not investment advice.